Douglas Maschino, in Pleasanton, KS - Pharmacist

Douglas Maschino, is a Pharmacist based in Pleasanton, Kansas. Douglas Maschino is licensed to practice in Kansas (license number 1-11224) and his current practice location is 20620 E 600 Rd, Pleasanton, Kansas. He can be reached at his office (for appointments etc.) via phone at (913) 352-8733.

NPI number for Douglas Maschino is 1740368489 and his current mailing address is Po Box 500, Pleasanton, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1740368489.

Contact Information

	Douglas Maschino,
	20620 E 600 Rd, Pleasanton, KS 66075
	(913) 352-8733
	Not Available

Healthcare Provider's Profile

Full Name	Douglas Maschino
Gender	Male
Speciality	Pharmacist
Location	20620 E 600 Rd, Pleasanton, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1740368489
Provider Enumeration Date: 11/01/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Douglas Maschino such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1740368489	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	1-11224 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Douglas Maschino is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Douglas Maschino, Po Box 500, Pleasanton, KS 66075-0500 Ph: () -	Douglas Maschino, 20620 E 600 Rd, Pleasanton, KS 66075 Ph: (913) 352-8733

News Archive

State highlights: Illinois Medicaid digital shift delayed; N.C. hospitals fight cuts; heroin in New England

Alexian Brothers Health System is suspending its effort to launch a new Medicaid program, blaming the difficulty of connecting physicians using different electronic records systems. The Arlington Heights, Ill.-based health system was spearheading a so-called accountable care entity (ACE) to coordinate the care of about 46,000 patients on Medicaid, the state-federal health insurance program for the poor and disabled. The ACEs are a form of managed care, one of Gov. Pat Quinn's initiatives to focus on preventative treatment to keep patients healthy and reduce health care costs (Schorsch, 6/17).

Closure of holes in heart important treatment for young stroke patients

Placement of devices to close holes in the heart is a successful treatment for young stroke patients, finds a study involving three medical centers.

Plans for schools to hold spare adrenaline auto-injector continue to progress positively

The plans for an amendment to legislation which will allow all state schools to hold a spare adrenaline injector for use in case of emergencies continues to progress positively. We have been informed today by the Department of Health that this change is to come into effect in October of this year.

EnGeneIC begins Phase 1 Tailored-EDV trial for advanced solid tumor

EnGeneIC Ltd., an emerging biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, today announced that the first patient has been dosed in its Phase 1 Tailored-EDV trial. The trial is being conducted at the Northern Cancer Institute in Sydney, Australia.

Douglas Maschino, - Pharmacist in Pleasanton, KS